The stock of Smith & Nephew plc ADR (NYSE: SNN) has increased by 1.43 when compared to last closing price of 28.58.Despite this, the company has seen a loss of -3.72% in its stock price over the last five trading days. globenewswire.com reported 2025-06-18 that Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a strategic partnership with Standard Health www.standardhealth.co.uk to support the development of the first-ever Orthopaedic Ambulatory Surgery Centre in the UK. Based in Poole, Dorset, the new centre will offer NHS and private patients access to leading joint repair and replacement technology for conditions such as rotator cuff repair, ACL reconstruction, knee and hip replacements, and foot & ankle/hand & wrist procedures.
Is It Worth Investing in Smith & Nephew plc ADR (NYSE: SNN) Right Now?
The price-to-earnings ratio for Smith & Nephew plc ADR (NYSE: SNN) is above average at 30.97x, Company’s 36-month beta value is 0.71.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for SNN is 437.07M, and currently, short sellers hold a 0.67% ratio of that floaft. The average trading volume of SNN on June 20, 2025 was 862.72K shares.
SNN’s Market Performance
The stock of Smith & Nephew plc ADR (SNN) has seen a -3.72% decrease in the past week, with a -1.43% drop in the past month, and a 1.86% gain in the past quarter. The volatility ratio for the week is 1.25%, and the volatility levels for the past 30 days are at 1.38% for SNN. The simple moving average for the last 20 days is -0.98% for SNN’s stock, with a simple moving average of 5.61% for the last 200 days.
SNN Trading at 2.95% from the 50-Day Moving Average
After a stumble in the market that brought SNN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -8.61% of loss for the given period.
Stock Fundamentals for SNN
Current profitability levels for the company are sitting at:
- 0.13 for the present operating margin
- 0.7 for the gross margin
The net margin for Smith & Nephew plc ADR stands at 0.06. The total capital return value is set at 0.06. Equity return is now at value 7.82, with 4.03 for asset returns.
Based on Smith & Nephew plc ADR (SNN), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at 0.15.
Currently, EBITDA for the company is 1.24 billion with net debt to EBITDA at 3.41. When we switch over and look at the enterprise to sales, we see a ratio of 3.64. The receivables turnover for the company is 3.51for trailing twelve months and the total asset turnover is 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.89.
Conclusion
In a nutshell, Smith & Nephew plc ADR (SNN) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
